8-Bromo-3-iodoimidazo[1,2-a]pyrazine, 95.0%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 25 µl, 1702 RN, 1 piece

2-(5-Amino-2-methylphenyl)acetic acid, 98%, 1g

5-Bromo-4-nitrobenzo[c][1,2,5]thiadiazole, 95.0%, 250mg

Nonadecane>99.0%(GC)400g

methyl (3-aminophenyl)carbamate hydrochloride, 95.0%, 1g

Ethyl 5-bromo-2-methyl-3-nitrobenzoate, 97%, 1g

PIPERAZINE SUCCINATE, 95.0%, 25g

(R)-2-(((Benzyloxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid, 95.0%, 1g

6-(4-morpholinyl)-3(2H)-pyridazinone, 95.0%, 1g

1-TERT-BUTYL-3-PHENYL-1H-PYRAZOL-5-AMINE, 95.0%, 250mg

2-Chloro-4-methylpyrimidine, 98.0%, 10g

2-Methoxybenzonitrile>98.0%(GC)25g